Cuellar, Sandra <br/><br/>
Pharmacist perspectives and considerations for implementation of therapeutic oncology biosimilars in practice.  [electronic resource] 

 -  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists  Oct 2019 
 - 1725-1738 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1535-2900 
<br/><br/><label>Standard No.: </label>10.1093/ajhp/zxz190  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Immunological--therapeutic use<br/>Bevacizumab--therapeutic use<br/>Biosimilar Pharmaceuticals--therapeutic use<br/>Drug Approval--legislation & jurisprudence<br/>Drug Development--legislation & jurisprudence<br/>Humans<br/>Medical Oncology--methods<br/>Molecular Targeted Therapy--methods<br/>Neoplasms--drug therapy<br/>Pharmacists--organization & administration<br/>Pharmacy and Therapeutics Committee--legislation & jurisprudence<br/>Rituximab--therapeutic use<br/>Trastuzumab--therapeutic use<br/>United States<br/>United States Food and Drug Administration--legislation & jurisprudence